血浆N-聚糖特征与炎症性肠病特征相关
该研究通过质谱法分析2635例炎症性肠病(IBD)患者和996例对照的血浆N-聚糖组,发现IBD患者具有特定N-聚糖模式,可区分克罗恩病与溃疡性结肠炎,并与疾病部位、进展、用药及手术相关,结果在独立队列中重复验证。
要点
- IBD患者血浆N-聚糖中大型聚糖丰度升高,岩藻糖基化和半乳糖基化降低,唾液酸化升高。
- 克罗恩病与溃疡性结肠炎可通过更高的平分型、更低的半乳糖基化和更高的α2,3-唾液酸化区分。
- N-聚糖模式与疾病部位、进展、需更强效药物及手术相关,并在独立队列中重复验证。
核心结论
- 血浆N-聚糖谱可能用于IBD诊断及预测患者治疗反应。
研究设计与样本
- 研究分析了2635例IBD患者和996例对照的血浆总N-聚糖组,采用质谱法及连接特异性唾液酸衍生化技术。
- 发现队列来自意大利2家医院(1989例IBD患者和570例对照),验证队列来自美国1个医学中心(646例IBD患者和426例对照)。
主要发现
- 与对照相比,IBD患者血浆中大尺寸聚糖丰度更高,杂合型和高甘露糖结构相对丰度降低,岩藻糖基化降低,半乳糖基化降低,唾液酸化升高(α2,3-和α2,6-连接)。
- 基于更高的平分型、更低的半乳糖基化和更高的唾液酸化(α2,3-连接),可区分克罗恩病与溃疡性结肠炎患者的血浆。
- N-聚糖模式与疾病部位、疾病进展、需要更强效药物及手术相关,结果在大型独立队列中重复验证。
关键数值与推荐
- 63种糖型符合相对定量标准,并组合为78种衍生特征。
- 线性回归和逻辑回归用于检验血浆N-聚糖组与年龄、性别、克罗恩病、溃疡性结肠炎及IBD相关参数(如疾病部位、手术和用药、C反应蛋白水平、沉降率)的关联。
临床怎么用
- 这些N-聚糖谱可能用于诊断和预测患者对治疗的反应。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Biomarkers are needed for early detection of Crohn's disease (CD) and ulcerative colitis (UC) or to predict patient outcomes. Glycosylation is a common and complex posttranslational modification of proteins that affects their structure and activity. We compared plasma N-glycosylation profiles between patients with CD or UC and healthy individuals (controls). METHODS: We analyzed the total plasma N-glycomes of 2635 patients with inflammatory bowel diseases and 996 controls by mass spectrometry with a linkage-specific sialic acid derivatization technique. Plasma samples were acquired from 2 hospitals in Italy (discovery cohort, 1989 patients with inflammatory bowel disease [IBD] and 570 controls) and 1 medical center in the United States (validation cohort, 646 cases of IBD and 426 controls). Sixty-three glycoforms met our criteria for relative quantification and were extracted from the raw data with the software MassyTools. Common features shared by the glycan compositions were combined in 78 derived traits, including the number of antennae of complex-type glycans and levels of fucosylation, bisection, galactosylation, and sialylation. Associations of plasma N-glycomes with age, sex, CD, UC, and IBD-related parameters such as disease location, surgery and medication, level of C-reactive protein, and sedimentation rate were tested by linear and logistic regression. RESULTS: Plasma samples from patients with IBD had a higher abundance of large-size glycans compared with controls, a decreased relative abundance of hybrid and high-mannose structures, lower fucosylation, lower galactosylation, and higher sialylation (α2,3- and α2,6-linked). We could discriminate plasma from patients with CD from that of patients with UC based on higher bisection, lower galactosylation, and higher sialylation (α2,3-linked). Glycosylation patterns were associated with disease location and progression, the need for a more potent medication, and surgery. These results were replicated in a large independent cohort. CONCLUSIONS: We performed high-throughput analysis to compare total plasma N-glycomes of individuals with vs without IBD and to identify patterns associated with disease features and the need for treatment. These profiles might be used in diagnosis and for predicting patients' responses to treatment.
引用
- Clerc F, Novokmet M, Dotz V, et al. Plasma N-Glycan Signatures Are Associated With Features of Inflammatory Bowel Diseases. Gastroenterology. 2018. PMID: 29792883. doi:10.1053/j.gastro.2018.05.030
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。